Dymeka Harrison, Chief Commercial Officer; Mathew Sargent, Chief Business Officer; and Gisela Paulsen, Chief Operating Officer join executive teamAppointments to Harbinger Health's industry-leading executive team add extensive experience across the diagnostics and oncology industries CAMBRIDGE, Mass., Sept.

Dymeka Harrison，首席商务官；首席商务官Mathew Sargent；首席运营官Gisela Paulsen加入了Harbinger Health行业领先的执行团队的执行团队任命，为马萨诸塞州剑桥的诊断和肿瘤行业增加了丰富的经验。

6, 2023 /PRNewswire/ -- Harbinger Health, a biotechnology company pioneering new technologies to fundamentally change cancer screening and detection, announced today the appointment of Dymeka Harrison as Chief Commercial Officer (CCO), Mathew Sargent as Chief Business Officer (CBO), and Gisela Paulsen as Chief Operating Officer (COO), positioning the Company for continued growth and platform and product advancement..

62023/PRNewswire/-开创从根本上改变癌症筛查和检测新技术的生物技术公司Harbinger Health今天宣布任命Dymeka Harrison担任首席商业官（CCO），Mathew Sargent担任首席商务官（CBO），Gisela Paulsen担任首席运营官（COO），定位公司继续发展，平台和产品进步。。

Continue Reading

继续阅读

TOP ROW L-R: Mathew Sargent, Gisela Paulsen, Vincent Lozada, May Orfali, Dymeka Harrison, Tony Shuber; BOTTOM ROW L-R: David Lambe, Leila Gjika, Stephen Hahn, Kieran Chacko

上排L-R:Mathew Sargent，Gisela Paulsen，Vincent Lozada，May Orfali，Dymeka Harrison，Tony Shuber；下排L-R:David Lambe，Leila Gjika，Stephen Hahn，Kieran Chacko

PHOTO CREDIT: Harbinger Health

照片来源：Harbinger Health

Mses. Harrison and Paulsen and Mr. Sargent join Harbinger's existing executive team, which includes Stephen Hahn, M.D., CEO; Vincent Lozada, CFO; May Orfali, M.D., CMO; Tony Shuber, Chief Innovation Officer; Kieran Chacko, Head of Strategy; David Lambe, SVP, Portfolio Strategy and Operations; and Leila Gjika, VP, Head of Human Resources..

毫秒。Harrison和Paulsen以及Sargent先生加入了Harbinger现有的执行团队，其中包括Stephen Hahn，医学博士，首席执行官；CFO Vincent Lozada；May Orfali，医学博士，CMO；首席创新官托尼·舒伯；战略负责人Kieran Chacko；David Lambe，SVP，投资组合战略和运营；和人力资源总监Leila Gjika。。

'Harbinger is laser-focused on our mission to create a new cancer screening paradigm by delivering accessible and low-cost early-stage screening tools,' said Dr. Hahn. 'Dymeka, Matt and Gisela strengthen our leadership team, expanding our collective expertise across diagnostics, commercialization, biotechnology finance, and data science as we advance our product platform and prepare to launch our first products in 2025.'.

哈恩博士说：“先兆激光专注于我们的使命，即通过提供可用且低成本的早期筛查工具来创建新的癌症筛查范例。”随着我们推进产品平台并准备在2025年推出我们的第一批产品，Dymeka，Matt和Gisela加强了我们的领导团队，扩大了我们在诊断，商业化，生物技术金融和数据科学方面的集体专业知识。

Dymeka Harrison joined as Chief Commercial Officer with over 20 years of experience in the diagnostics industry. In her newly appointed role, Ms. Harrison will oversee the execution of Harbinger's commercial strategy and launch of Harbinger's suite of cancer detection products. She most recently served as Chief Commercial Officer at Foundation Medicine, where she led global clinical and commercial strategies for all product lines.

Dymeka Harrison加入了首席商业官，在诊断行业拥有20多年的经验。在她新任命的角色中，哈里森女士将监督Harbinger商业战略的执行并启动Harbinger的癌症检测产品套件。她最近担任Foundation Medicine的首席商业官，在那里她领导所有产品系列的全球临床和商业战略。

Previously, she was Head of Strategic Marketing at Abbott Laboratories' Rapid Diagnostics Division, overseeing global marketing efforts. Ms. Harrison earned an Executive Master of Business Administration degree from Georgia State University, as well as a Bachelor of Science in both Manufacturing Engineering as well as Computer Technology and Electronics Engineering from North Carolina A&T State University..

此前，她曾担任雅培实验室快速诊断部门的战略营销负责人，负责监督全球营销工作。哈里森女士获得佐治亚州立大学商业管理硕士学位，以及北卡罗来纳州a＆T州立大学制造工程以及计算机技术与电子工程学士学位。。

Mathew Sargent was appointed Chief Business Officer and will drive Harbinger's growth and expansion, with a keen focus on optimizing partnerships across the organization in his new role. Mr. Sargent brings over 20 years of deep expertise in the oncology diagnostic industry. Before joining Harbinger, he held the role of Vice President of Commercial Oncology at Hologic, following the acquisition of Biotheranostics, where he served as Chief Commercial Officer.

Mathew Sargent被任命为首席商务官，将推动Harbinger的增长和扩张，热衷于优化整个组织的合作伙伴关系以发挥其新的作用。Sargent先生在肿瘤诊断行业拥有20多年的深入专业知识。在加入Harbinger之前，他在收购Biotheranostics后担任Hologic商业肿瘤学副总裁，并担任首席商业官。

Earlier in his career, he held roles of increasing responsibility including the first Vice President of Oncology Sales at Caris Life Sciences. Mr. Sargent holds a Master of Business Administration, Technology Management from Pepperdine University; a Master of Science in Natural Sciences, Cancer Physiology from the University of Buffalo; and a Bachelor of Science in Biology with a focus in Anatomy and Animal Physiology from Cornell University.

在他职业生涯的早期，他担任越来越重要的角色，包括Caris Life Sciences的肿瘤销售第一副总裁。Sargent先生担任佩珀丁大学技术管理业务管理硕士；布法罗大学自然科学硕士，癌症生理学硕士；以及康奈尔大学解剖学和动物生理学专业的生物学科学学士。

Mr. Sargent began his career in diagnostics as an Oncology Research Fellow at the Roswell Park Cancer Institute in Buffalo, New York..

Sargent先生在纽约布法罗罗斯威尔公园癌症研究所担任肿瘤学研究员，开始从事诊断工作。。

Gisela Paulsen joined Harbinger as Chief Operating Officer, bringing over 25 years of expertise in the life sciences industry to the team. She brings experience from executive roles at leading diagnostics companies Oncocyte Corporation, Exact Sciences (legacy Genomic Health) and Genentech/Roche across functions including commercial, program management, quality and regulatory, and other administrative functions.

Gisela Paulsen加入了Harbinger担任首席运营官，为该团队带来了25年的生命科学行业专业知识。她从领先的诊断公司Oncocyte Corporation，Exact Sciences（传统基因组健康）和Genentech/Roche的执行角色中获得经验，涉及商业，计划管理，质量和监管以及其他管理职能等职能。

Aside from her position at Harbinger Health, Ms. Paulsen is also Vice Chair of the Healthcare Businesswomen Association where she has led nominations, strategies and digital transformation committees. In 2019, she was named one of the 100 Most Inspiring People in the Life-Sciences Industry list by PharmaVOICE.

除了在Harbinger Health的职位外，Paulsen女士还是医疗保健女性协会的副主席，负责提名，战略和数字转型委员会。2019年，她被PharmaVOICE评为生命科学行业名单上最鼓舞人心的100人之一。

Ms. Paulsen graduated from Uppsala University in Sweden with a Master of Science in Pharmaceutics and Drug Delivery, and a Bachelor of Science in Pharmacy..

Paulsen女士毕业于瑞典乌普萨拉大学，拥有药剂学和药物输送科学硕士学位，药学科学学士学位。。

About Harbinger HealthHarbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing low-cost, multi-cancer blood tests.

关于Harbinger HealthHarbinger Health正在开创早期癌症的检测，并为癌症筛查，诊断和管理提供基础性的新方法。该公司将人工智能的进步与癌症初期生物学的专有见解相结合，在癌症可见或有症状之前识别癌症，目的是开发低成本，多癌症的血液检查。

Harbinger envisions a future where, instead of keeping cancer from spreading, it could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems and societies. Harbinger was founded by Flagship Pioneering after three years of foundational research in its Labs unit and launched in 2020.

先兆设想了一个未来，在这个未来，癌症不是防止癌症扩散，而是可以防止癌症形成，使癌症诊断成为一个需要解决的常规健康问题，而不是担心生活改变事件会对人们，医疗系统和社会产生深远影响。Harbinger由Flagship开拓公司在其实验室部门进行了三年的基础研究，并于2020年启动。

Learn more about Harbinger by visiting Harbinger-Health.com or following us on Twitter (@harbingerhlth) and LinkedIn.Media Contact[email protected]SOURCE Harbinger Health.

通过访问Harbinger Health.com或在Twitter（@harbingerhlth）和LinkedIn.Media联系人[电子邮件保护]SOURCE Harbinger Health上关注我们，了解有关Harbinger的更多信息。